Table 2. Correlation of NFIs with survival outcomes in breast cancer patients.
| Gene | Affymetrix ID | Survival outcome | No. of cases | Cut-off value | HR | 95% CI | p-Value |
|---|---|---|---|---|---|---|---|
| NFIA | 226806_s_at | OS | 1,402 | 1,490 | 0.9 | [0.65–1.22] | 0.49 |
| RFS | 3,951 | 1,519 | 0.72 | [0.61–0.84] | <0.001 | ||
| DMFS | 1,746 | 1,484 | 0.94 | [0.68–1.3] | 0.72 | ||
| PPS | 414 | 1,488 | 1.03 | [0.72–1.47] | 0.88 | ||
| NFIB | 213029_at | OS | 1,402 | 1,292 | 0.94 | [0.76–1.16] | 0.56 |
| RFS | 3,951 | 1,216 | 1.1 | [0.99–1.23] | 0.086 | ||
| DMFS | 1,746 | 1,226 | 1.09 | [0.9–1.32] | 0.39 | ||
| PPS | 414 | 1,277 | 1.2 | [0.94–1.53] | 0.14 | ||
| NFIC | 226377_at | OS | 1,402 | 690 | 0.79 | [0.58–1.08] | 0.14 |
| RFS | 3,951 | 1,155 | 0.84 | [0.72–0.98] | 0.025 | ||
| DMFS | 1,746 | 1,005 | 0.85 | [0.61–1.17] | 0.31 | ||
| PPS | 414 | 657 | 1.36 | [0.96–1.94] | 0.086 | ||
| NFIX | 227400_at | OS | 1,402 | 585 | 0.71 | [0.52–0.97] | 0.033 |
| RFS | 3,951 | 723 | 0.82 | [0.7–0.95] | 0.0098 | ||
| DMFS | 1,746 | 684 | 0.96 | [0.7–1.33] | 0.81 | ||
| PPS | 414 | 539 | 0.92 | [0.65–1.32] | 0.67 |
Note:
HR, hazard ratio; CI, confidence interval; OS, overall survival; RFS, progression free survival; DMFS, distant metastasis free survival; PPS, post progression survival.